Cargando…
Endomyocardial biopsy-proven fulminant lymphocytic myocarditis presenting with mid-apical ballooning
Autores principales: | Miyamoto, Ryota, Ise, Takayuki, Yoshida, Tomoya, Sata, Masataka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057820/ https://www.ncbi.nlm.nih.gov/pubmed/37006797 http://dx.doi.org/10.1093/ehjcr/ytad123 |
Ejemplares similares
-
Microthrombosis as a cause of fulminant myocarditis-like presentation with COVID-19 proven by endomyocardial biopsy
por: Nakatani, Satoshi, et al.
Publicado: (2022) -
Unconventional Approach: Steroid Treatment for Eosinophilic Myocarditis Despite Negative Endomyocardial Biopsy
por: Vaysblat, Michael, et al.
Publicado: (2023) -
Multimodality Imaging Guidance in Fulminant Myocarditis: When Endomyocardial Biopsy Is Not Amenable
por: Kim, Jin Young, et al.
Publicado: (2020) -
Fulminant myocarditis and acute heart failure in the light of new American Heart Association 2020 guidelines. Mechanical cardiac support and endomyocardial biopsy. What should be first?
por: Płonka, Joanna, et al.
Publicado: (2022) -
COVID-Induced Fulminant Myocarditis
por: Rodriguez Guerra, Miguel A, et al.
Publicado: (2022)